SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : RMGG

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DR. MEADE who wrote ()1/28/2000 2:38:00 PM
From: dkgross  Read Replies (1) of 1170
 
RMGG Announces Appointment of Brian A.Hodge <RMGG.OB>

Rocky Mountain Ginseng, Inc. Announces Appointment of Brian A. Hodge as President

VANCOUVER, British Columbia--(BUSINESS WIRE)--Jan. 28, 2000-- Rocky Mountain Ginseng, Inc. (OTCBB:RMGG) is pleased to announce Brian A. Hodge has accepted the Position of President of Rocky Mountain Ginseng, Inc.

Mr. Hodge has been instrumental in the purchase of the Chinese pharmaceutical company in February 1999, and will continue as Managing Director of Rocky Mountain (Fuzhou) Drug Co. Ltd. in Fuzhou, China. Of his many successes, Mr. Hodge supervised the implementation and completion of the new manufacturing plant which meets the stringent international GMP (Good Manufacturing Practices) standards, thus allowing RMGG to export product to international markets.

He was also instrumental in obtaining a major contract with a large Chinese drug chain, Quanhou Da Tong Medicine Co. Ltd., which has over 500 stores in China. Brian Hodge received his degree of Bachelor of Science in Agriculture from North Dakota State University. He has graduated from numerous NDSU post-graduate courses in economics and psychology, as well as extensive marketing courses from Waterloo University and the University of Western Ontario.

ABOUT ROCKY MOUNTAIN GINSENG, INC. Rocky Mountain Ginseng, Inc.'s head office is located in British Columbia, Canada. The company exports American ginseng to China as well as manufactures and processes American ginseng products in China. Rocky Mountain Ginseng, Inc. holds exclusive world processing and distribution rights to several innovative value added ginseng products developed in North America.

Rocky Mountain Ginseng, Inc. purchased Fuzhou Fujian Drug Company located in China in February 1999. This acquisition included all necessary drug and hygiene licenses allowing the company to import, export, manufacture and distribute ginseng products in all provinces of China. The company has completed the construction of its new office and manufacturing facility in the city of Fuzhou and is currently producing traditional ginseng products for the Chinese Market. The Chinese factory employs 27 people in processing, sales, accounting and management. Rocky Mountain (Fuzhou) Drug Co. Ltd. is the first wholly owned American Company in the Fujian province.

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Expression of future goals and similar expressions reflecting something other than historical fact involve risks and uncertainties. The actual results the company achieves may differ materially from any forward-looking statements due to such risks and uncertainties

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext